Clincosm LogoSign in Get a demo

Solid Tumor

Showing NaN - NaN of 52
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)

Terminated
Has Results
  • Solid Tumor
  • +6 more
  • Birmingham, Alabama
  • +8 more
Feb 16, 2022

Solid Tumor Trial in San Antonio, Seoul (TU2218, Anti-PD-1 antibody)

Recruiting
  • Solid Tumor
  • San Antonio, Texas
    NEXT Oncology
Jan 10, 2022

Lung Cancer, Solid Tumor, Gastric Cancer Trial in Denmark, United States (Pemigatinib, Gemcitabine + Cisplatin, Pembrolizumab)

Completed
  • Lung Cancer
  • +10 more
  • Birmingham, Alabama
  • +19 more
Jan 4, 2022

Metastatic Cancer, Solid Tumor Trial in Canada, United States (Sym021, Sym024)

Recruiting
  • Metastatic Cancer
  • Solid Tumor
  • Grand Rapids, Michigan
  • +3 more
Dec 16, 2021

Metastatic Cancer, Solid Tumor, Lymphoma Trial in Canada, United States (Sym023)

Completed
Has Results
  • Metastatic Cancer
  • +2 more
  • Grand Rapids, Michigan
  • +3 more
Oct 11, 2021

Solid Tumor Trial in Boston, Buffalo, San Antonio (Oraxol)

Completed
  • Solid Tumor
  • Boston, Massachusetts
  • +2 more
Sep 6, 2021

Solid Tumor Trial in San Antonio (ADG116)

Terminated
  • Solid Tumor
  • San Antonio, Texas
    NEXT Oncology
Sep 3, 2021

Solid Tumor Trial in United States (BNT152, BNT153)

Recruiting
  • Solid Tumor
  • New Haven, Connecticut
  • +3 more
Sep 8, 2021

Solid Tumor Trial in Worldwide (LY3321367, LY3300054)

Active, not recruiting
  • Solid Tumor
  • Tucson, Arizona
  • +14 more
Sep 2, 2021

Solid Tumor, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in United States (ZN-c3)

Recruiting
  • Solid Tumor
  • +9 more
  • Tucson, Arizona
  • +3 more
Aug 12, 2021

Solid Tumor, Lymphoma Trial in Korea, Republic of, United States (IMC-002)

Recruiting
  • Solid Tumor
  • Lymphoma
  • IMC-002
  • Saint Louis, Missouri
  • +3 more
Jun 29, 2021

Cancer, Solid Tumor Trial in San Antonio (Eribulin, Lenvatinib)

Unknown status
  • Cancer
  • Solid Tumor
  • San Antonio, Texas
    Cancer Therapy and Research Center University of Texas Health Sc
Mar 1, 2021

Solid Tumor, Colorectal Cancer Trial in United States (Magrolimab, Cetuximab)

Completed
Has Results
  • Solid Tumor
  • Colorectal Cancer
  • Los Angeles, California
  • +7 more
Feb 8, 2021

Melanoma, Metastatic Melanoma, Solid Tumor Trial in United Kingdom, United States (MLN2480)

Completed
Has Results
  • Melanoma
  • +3 more
  • San Francisco, California
  • +15 more
Jul 28, 2020

Solid Tumor Trial in Worldwide (Atezolizumab)

Terminated
Has Results
  • Solid Tumor
  • Little Rock, Arkansas
  • +29 more
Feb 24, 2020

Solid Tumor, Metastatic Bladder Cancer Trial in United States (RX-3117)

Completed
  • Solid Tumor
  • Metastatic Bladder Cancer
  • Birmingham, Alabama
  • +11 more
Jan 3, 2020

Solid Tumor Trial in Phoenix, Rochester, San Antonio (Oradoxel)

Unknown status
  • Solid Tumor
  • Phoenix, Arizona
  • +2 more
Oct 15, 2019

Solid Tumor Trial in Canada, United States (Cetuximab, Cisplatin, 5 - Fluorouracil)

Completed
Has Results
  • Solid Tumor
  • Fayetteville, Arkansas
  • +6 more
Sep 10, 2019

Solid Tumor Trial in Grand Rapids, San Antonio (LZM009,recombinant humanized anti-PD-1 mAb for injection)

Completed
  • Solid Tumor
  • LZM009,recombinant humanized anti-PD-1 monoclonal antibody for injection
  • Grand Rapids, Michigan
  • +1 more
Aug 1, 2019

Malignant Lymphoma of Extranodal and/or Solid Organ Site, Solid Tumor Trial in San Antonio (CZ48)

Unknown status
  • Malignant Lymphoma of Extranodal and/or Solid Organ Site
  • Solid Tumor
  • San Antonio, Texas
    University of Texas Health Science Center
Jul 22, 2019

Solid Tumor, Hematologic Malignancies Trial in United States (BGJ398)

Terminated
Has Results
  • Solid Tumor
  • Hematologic Malignancies
  • Birmingham, Alabama
  • +55 more
May 28, 2019

Solid Tumor Trial in United States (Hu5F9-G4)

Completed
  • Solid Tumor
  • Stanford, California
  • +5 more
Feb 1, 2019

Solid Tumor Trial in United States (MSC2363318A, MSC2363318A plus Trastuzumab, MSC2363318A plus Tamoxifen)

Completed
  • Solid Tumor
  • Birmingham, Alabama
  • +14 more
Sep 18, 2018

Solid Tumor, Malignant Lymphoma, Tumor Trial in United States (ARQ 092)

Completed
  • Solid Tumor
  • +2 more
  • ARQ 092
  • Birmingham, Alabama
  • +6 more
Oct 19, 2017

Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase, Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS Trial in

Completed
  • Advanced Malignancies
  • +4 more
  • Orange, California
  • +5 more
Jun 27, 2016